United States Biotechnology & Medical Research

Generation Bio Co (GBIO)

Track

Track

Ticker: GBIO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Generation Bio Co. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Quinn Anthony G. Non-Executive Director
Transaction date
Purchase
Price
408.82
Quantity 95,245 -43.4%
Value US$2,710,862
2.5
Quinn Anthony G. Non-Executive Director
Transaction date
Purchase
Price
178.24
Quantity 4,968 +12.6%
Value US$2,272,906
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
369.66
Quantity 89,967 +5.3%
Value US$4,990,929
ANTOINETTE D PAONE Officer Officer
Transaction date
Proposed sale
Price
2.74
Quantity 6,719
Value US$18,410
Samayoa Phillip CHIEF STRATEGY OFFICER Officer
Transaction date
Planned sale
Price
1.62
Quantity 2,445 -2.2%
Value US$3,961
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
1.62
Quantity 2,445 -29.6%
Value US$3,961
3.7
Appelhans Dannielle Non-Executive Director
Transaction date
Purchase
Price
1.79
Quantity 7,363 +inf%
Value US$13,180
3.7
Appelhans Dannielle Non-Executive Director
Transaction date
Purchase
Price
1.82
Quantity 637 +5.3%
Value US$1,159
3.7
Appelhans Dannielle Non-Executive Director
Transaction date
Purchase
Price
1.50
Quantity 12,000 +inf%
Value US$18,000
3.8
Rowland Charles A Jr Non-Executive Director
Transaction date
Purchase
Price
1.50
Quantity 150,000 +39.0%
Value US$225,000
2.5
Quinn Anthony G. Non-Executive Director
Transaction date
Purchase
Price
1.41
Quantity 88,495 +inf%
Value US$124,778
3.8
Rowland Charles A Jr Non-Executive Director
Transaction date
Purchase
Price
1.31
Quantity 192,960 +100.6%
Value US$252,778
4.0
Nicholson Donald William Non-Executive Director
Transaction date
Purchase
Price
1.44
Quantity 100,000 +88.0%
Value US$144,000
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
4.93
Quantity 3,116 -51.7%
Value US$15,362
Samayoa Phillip CHIEF STRATEGY OFFICER Officer
Transaction date
Planned sale
Price
5.29
Quantity 3,116 -3.0%
Value US$16,484
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
4.61
Quantity 2,914 -100.0%
Value US$13,434
ANTOINETTE D PAONE Officer Officer
Transaction date
Proposed sale
Price
4.61
Quantity 2,914
Value US$13,444
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
5.56
Quantity 2,695 -100.0%
Value US$14,984
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
4.57
Quantity 1,865 -100.0%
Value US$8,523
Samayoa Phillip CHIEF STRATEGY OFFICER Officer
Transaction date
Planned sale
Price
5.11
Quantity 1,865 -1.9%
Value US$9,530
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
5.03
Quantity 2,914 -100.0%
Value US$14,657
3.8
Rowland Charles A Jr Non-Executive Director
Transaction date
Purchase
Price
5.26
Quantity 15,750 +8.9%
Value US$82,845
3.8
Rowland Charles A Jr Non-Executive Director
Transaction date
Purchase
Price
5.48
Quantity 33,481 +23.5%
Value US$183,476
3.8
Rowland Charles A Jr Non-Executive Director
Transaction date
Purchase
Price
5.41
Quantity 17,147 +13.7%
Value US$92,765
Paone Antoinette CHIEF OPERATING OFFICER Officer
Transaction date
Planned sale
Price
5.32
Quantity 4,610 -62.0%
Value US$24,525
3.8
Rowland Charles A Jr Non-Executive Director
Transaction date
Purchase
Price
5.30
Quantity 5,600 +4.7%
Value US$29,652
3.8
Rowland Charles A Jr Non-Executive Director
Transaction date
Purchase
Price
5.20
Quantity 18,784 +18.6%
Value US$97,752
4.0
Nicholson Donald William Non-Executive Director
Transaction date
Purchase
Price
4.71
Quantity 8,126 +7.7%
Value US$38,273
4.0
Nicholson Donald William Non-Executive Director
Transaction date
Purchase
Price
4.79
Quantity 2,293 +2.2%
Value US$10,983
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
24.59
Quantity 30 -4.7%
Value US$738
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
24.59
Quantity 16,556 -100.0%
Value US$407,112
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.24
Quantity 24 -3.6%
Value US$606
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.24
Quantity 13,089 -44.2%
Value US$330,366
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.70
Quantity 95 -12.5%
Value US$2,442
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.70
Quantity 51,294 -63.4%
Value US$1,318,256
Stanton Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
26.74
Quantity 800 -0.4%
Value US$21,392
Stanton Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
25.69
Quantity 2,200 -1.1%
Value US$56,518
Stanton Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
25.04
Quantity 1,500 -0.8%
Value US$37,560
Stanton Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
24.19
Quantity 100 -0.1%
Value US$2,419
Stanton Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
23.36
Quantity 400 -0.2%
Value US$9,344
Stanton Matthew CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
22.18
Quantity 1,000 -0.5%
Value US$22,180
Kerr Douglas CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
25.39
Quantity 1,889 -0.6%
Value US$47,962
Kerr Douglas CHIEF MEDICAL OFFICER Officer
Transaction date
Planned sale
Price
24.99
Quantity 1,629 -0.5%
Value US$40,709
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
26.39
Quantity 8 -1.3%
Value US$211
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.77
Quantity 50 -7.5%
Value US$1,288
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
26.39
Quantity 4,092 -100.0%
Value US$107,988
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.77
Quantity 26,858 -86.8%
Value US$692,131
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.69
Quantity 53 -7.4%
Value US$1,362
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.08
Quantity 63 -8.1%
Value US$1,580
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.69
Quantity 28,331 -47.8%
Value US$727,823
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.08
Quantity 34,162 -36.6%
Value US$856,783
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.20
Quantity 47 -5.7%
Value US$1,184
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
24.76
Quantity 61 -6.9%
Value US$1,510
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.20
Quantity 25,208 -21.2%
Value US$635,242
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
24.76
Quantity 33,261 -21.9%
Value US$823,542
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
25.12
Quantity 7 -0.8%
Value US$176
3.5
Rhodes Jason P Non-Executive Director
Transaction date
Planned sale
Price
24.82
Quantity 111 -11.0%
Value US$2,755
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-14 2025-01-13 B Purchase
2.5
Quinn Anthony G.
Non-Executive Director
95,245 -43.4%
408.82
US$2,710,862 		95,245 -43.4% 408.82 US$2,710,862
2025-01-14 2025-01-10 B Purchase
2.5
Quinn Anthony G.
Non-Executive Director
4,968 +12.6%
178.24
US$2,272,906 		4,968 +12.6% 178.24 US$2,272,906
2024-07-03 2024-07-01 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
89,967 +5.3%
369.66
US$4,990,929 		89,967 +5.3% 369.66 US$4,990,929
2024-07-01 2024-07-01 PrS Proposed sale
ANTOINETTE D PAONE

Officer

Officer
6,719
2.74
US$18,410 		6,719 2.74 US$18,410
2024-01-03 2024-01-02 PlS Planned sale
Samayoa Phillip

CHIEF STRATEGY OFFICER

Officer
2,445 -2.2%
1.62
US$3,961 		2,445 -2.2% 1.62 US$3,961
2024-01-03 2024-01-02 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
2,445 -29.6%
1.62
US$3,961 		2,445 -29.6% 1.62 US$3,961
2023-12-11 2023-12-08 B Purchase
3.7
Appelhans Dannielle
Non-Executive Director
7,363 +inf%
1.79
US$13,180 		7,363 +inf% 1.79 US$13,180
2023-12-11 2023-12-08 B Purchase
3.7
Appelhans Dannielle
Non-Executive Director
637 +5.3%
1.82
US$1,159 		637 +5.3% 1.82 US$1,159
2023-12-06 2023-12-04 B Purchase
3.7
Appelhans Dannielle
Non-Executive Director
12,000 +inf%
1.50
US$18,000 		12,000 +inf% 1.50 US$18,000
2023-12-05 2023-12-04 B Purchase
3.8
Rowland Charles A Jr
Non-Executive Director
150,000 +39.0%
1.50
US$225,000 		150,000 +39.0% 1.50 US$225,000
2023-12-05 2023-12-01 B Purchase
2.5
Quinn Anthony G.
Non-Executive Director
88,495 +inf%
1.41
US$124,778 		88,495 +inf% 1.41 US$124,778
2023-12-05 2023-12-01 B Purchase
3.8
Rowland Charles A Jr
Non-Executive Director
192,960 +100.6%
1.31
US$252,778 		192,960 +100.6% 1.31 US$252,778
2023-12-05 2023-12-01 B Purchase
4.0
Nicholson Donald William
Non-Executive Director
100,000 +88.0%
1.44
US$144,000 		100,000 +88.0% 1.44 US$144,000
2023-08-25 2023-08-23 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
3,116 -51.7%
4.93
US$15,362 		3,116 -51.7% 4.93 US$15,362
2023-07-05 2023-07-03 PlS Planned sale
Samayoa Phillip

CHIEF STRATEGY OFFICER

Officer
3,116 -3.0%
5.29
US$16,484 		3,116 -3.0% 5.29 US$16,484
2023-04-26 2023-04-25 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
2,914 -100.0%
4.61
US$13,434 		2,914 -100.0% 4.61 US$13,434
2023-04-25 2023-04-25 PrS Proposed sale
ANTOINETTE D PAONE

Officer

Officer
2,914
4.61
US$13,444 		2,914 4.61 US$13,444
2023-01-27 2023-01-26 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
2,695 -100.0%
5.56
US$14,984 		2,695 -100.0% 5.56 US$14,984
2023-01-11 2023-01-10 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
1,865 -100.0%
4.57
US$8,523 		1,865 -100.0% 4.57 US$8,523
2023-01-10 2023-01-09 PlS Planned sale
Samayoa Phillip

CHIEF STRATEGY OFFICER

Officer
1,865 -1.9%
5.11
US$9,530 		1,865 -1.9% 5.11 US$9,530
2022-10-28 2022-10-27 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
2,914 -100.0%
5.03
US$14,657 		2,914 -100.0% 5.03 US$14,657
2022-09-20 2022-09-19 B Purchase
3.8
Rowland Charles A Jr
Non-Executive Director
15,750 +8.9%
5.26
US$82,845 		15,750 +8.9% 5.26 US$82,845
2022-09-19 2022-09-16 B Purchase
3.8
Rowland Charles A Jr
Non-Executive Director
33,481 +23.5%
5.48
US$183,476 		33,481 +23.5% 5.48 US$183,476
2022-09-19 2022-09-15 B Purchase
3.8
Rowland Charles A Jr
Non-Executive Director
17,147 +13.7%
5.41
US$92,765 		17,147 +13.7% 5.41 US$92,765
2022-09-19 2022-09-15 PlS Planned sale
Paone Antoinette

CHIEF OPERATING OFFICER

Officer
4,610 -62.0%
5.32
US$24,525 		4,610 -62.0% 5.32 US$24,525
2022-09-15 2022-09-14 B Purchase
3.8
Rowland Charles A Jr
Non-Executive Director
5,600 +4.7%
5.30
US$29,652 		5,600 +4.7% 5.30 US$29,652
2022-09-15 2022-09-13 B Purchase
3.8
Rowland Charles A Jr
Non-Executive Director
18,784 +18.6%
5.20
US$97,752 		18,784 +18.6% 5.20 US$97,752
2022-03-11 2022-03-10 B Purchase
4.0
Nicholson Donald William
Non-Executive Director
8,126 +7.7%
4.71
US$38,273 		8,126 +7.7% 4.71 US$38,273
2022-03-11 2022-03-09 B Purchase
4.0
Nicholson Donald William
Non-Executive Director
2,293 +2.2%
4.79
US$10,983 		2,293 +2.2% 4.79 US$10,983
2021-09-29 2021-09-29 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
30 -4.7%
24.59
US$738 		30 -4.7% 24.59 US$738
2021-09-29 2021-09-29 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
16,556 -100.0%
24.59
US$407,112 		16,556 -100.0% 24.59 US$407,112
2021-09-29 2021-09-29 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
30 -4.7%
24.59
US$738 		30 -4.7% 24.59 US$738
2021-09-29 2021-09-29 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
16,556 -100.0%
24.59
US$407,112 		16,556 -100.0% 24.59 US$407,112
2021-09-29 2021-09-28 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
24 -3.6%
25.24
US$606 		24 -3.6% 25.24 US$606
2021-09-29 2021-09-28 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
13,089 -44.2%
25.24
US$330,366 		13,089 -44.2% 25.24 US$330,366
2021-09-29 2021-09-28 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
24 -3.6%
25.24
US$606 		24 -3.6% 25.24 US$606
2021-09-29 2021-09-28 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
13,089 -44.2%
25.24
US$330,366 		13,089 -44.2% 25.24 US$330,366
2021-09-29 2021-09-27 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
95 -12.5%
25.70
US$2,442 		95 -12.5% 25.70 US$2,442
2021-09-29 2021-09-27 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
51,294 -63.4%
25.70
US$1,318,256 		51,294 -63.4% 25.70 US$1,318,256
2021-09-29 2021-09-27 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
95 -12.5%
25.70
US$2,442 		95 -12.5% 25.70 US$2,442
2021-09-29 2021-09-27 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
51,294 -63.4%
25.70
US$1,318,256 		51,294 -63.4% 25.70 US$1,318,256
2021-09-14 2021-09-10 PlS Planned sale
Stanton Matthew

CHIEF SCIENTIFIC OFFICER

Officer
800 -0.4%
26.74
US$21,392 		800 -0.4% 26.74 US$21,392
2021-09-14 2021-09-10 PlS Planned sale
Stanton Matthew

CHIEF SCIENTIFIC OFFICER

Officer
2,200 -1.1%
25.69
US$56,518 		2,200 -1.1% 25.69 US$56,518
2021-08-25 2021-08-23 PlS Planned sale
Stanton Matthew

CHIEF SCIENTIFIC OFFICER

Officer
1,500 -0.8%
25.04
US$37,560 		1,500 -0.8% 25.04 US$37,560
2021-08-11 2021-08-10 PlS Planned sale
Stanton Matthew

CHIEF SCIENTIFIC OFFICER

Officer
100 -0.1%
24.19
US$2,419 		100 -0.1% 24.19 US$2,419
2021-08-11 2021-08-10 PlS Planned sale
Stanton Matthew

CHIEF SCIENTIFIC OFFICER

Officer
400 -0.2%
23.36
US$9,344 		400 -0.2% 23.36 US$9,344
2021-08-11 2021-08-10 PlS Planned sale
Stanton Matthew

CHIEF SCIENTIFIC OFFICER

Officer
1,000 -0.5%
22.18
US$22,180 		1,000 -0.5% 22.18 US$22,180
2021-07-12 2021-07-08 PlS Planned sale
Kerr Douglas

CHIEF MEDICAL OFFICER

Officer
1,889 -0.6%
25.39
US$47,962 		1,889 -0.6% 25.39 US$47,962
2021-07-12 2021-07-08 PlS Planned sale
Kerr Douglas

CHIEF MEDICAL OFFICER

Officer
1,629 -0.5%
24.99
US$40,709 		1,629 -0.5% 24.99 US$40,709
2021-06-28 2021-06-24 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
8 -1.3%
26.39
US$211 		8 -1.3% 26.39 US$211
2021-06-28 2021-06-24 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
50 -7.5%
25.77
US$1,288 		50 -7.5% 25.77 US$1,288
2021-06-28 2021-06-24 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
4,092 -100.0%
26.39
US$107,988 		4,092 -100.0% 26.39 US$107,988
2021-06-28 2021-06-24 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
26,858 -86.8%
25.77
US$692,131 		26,858 -86.8% 25.77 US$692,131
2021-06-28 2021-06-24 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
8 -1.3%
26.39
US$211 		8 -1.3% 26.39 US$211
2021-06-28 2021-06-24 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
50 -7.5%
25.77
US$1,288 		50 -7.5% 25.77 US$1,288
2021-06-28 2021-06-24 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
4,092 -100.0%
26.39
US$107,988 		4,092 -100.0% 26.39 US$107,988
2021-06-28 2021-06-24 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
26,858 -86.8%
25.77
US$692,131 		26,858 -86.8% 25.77 US$692,131
2021-06-23 2021-06-23 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
53 -7.4%
25.69
US$1,362 		53 -7.4% 25.69 US$1,362
2021-06-23 2021-06-23 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
63 -8.1%
25.08
US$1,580 		63 -8.1% 25.08 US$1,580
2021-06-23 2021-06-23 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
28,331 -47.8%
25.69
US$727,823 		28,331 -47.8% 25.69 US$727,823
2021-06-23 2021-06-23 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
34,162 -36.6%
25.08
US$856,783 		34,162 -36.6% 25.08 US$856,783
2021-06-23 2021-06-23 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
53 -7.4%
25.69
US$1,362 		53 -7.4% 25.69 US$1,362
2021-06-23 2021-06-23 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
63 -8.1%
25.08
US$1,580 		63 -8.1% 25.08 US$1,580
2021-06-23 2021-06-23 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
28,331 -47.8%
25.69
US$727,823 		28,331 -47.8% 25.69 US$727,823
2021-06-23 2021-06-23 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
34,162 -36.6%
25.08
US$856,783 		34,162 -36.6% 25.08 US$856,783
2021-06-23 2021-06-22 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
47 -5.7%
25.20
US$1,184 		47 -5.7% 25.20 US$1,184
2021-06-23 2021-06-22 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
61 -6.9%
24.76
US$1,510 		61 -6.9% 24.76 US$1,510
2021-06-23 2021-06-22 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
25,208 -21.2%
25.20
US$635,242 		25,208 -21.2% 25.20 US$635,242
2021-06-23 2021-06-22 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
33,261 -21.9%
24.76
US$823,542 		33,261 -21.9% 24.76 US$823,542
2021-06-23 2021-06-22 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
47 -5.7%
25.20
US$1,184 		47 -5.7% 25.20 US$1,184
2021-06-23 2021-06-22 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
61 -6.9%
24.76
US$1,510 		61 -6.9% 24.76 US$1,510
2021-06-23 2021-06-22 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
25,208 -21.2%
25.20
US$635,242 		25,208 -21.2% 25.20 US$635,242
2021-06-23 2021-06-22 PlS Planned sale
3.1
ATLAS VENTURE ASSOCIATES X, L.P.
Large shareholder
33,261 -21.9%
24.76
US$823,542 		33,261 -21.9% 24.76 US$823,542
2021-06-23 2021-06-21 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
7 -0.8%
25.12
US$176 		7 -0.8% 25.12 US$176
2021-06-23 2021-06-21 PlS Planned sale
3.5
Rhodes Jason P
Non-Executive Director
111 -11.0%
24.82
US$2,755 		111 -11.0% 24.82 US$2,755
Explore more

More insider trading research around Generation Bio Co

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America